129
12.
Michaelides M, Kaines A, Hamilton RD, et al. A prospective randomized
trial of intravitreal bevacizumab or laser therapy in the management of
diabetic macular edema (BOLT study) 12-month data: report 2. Ophthal-
mology 2010;117: (6):1078-1086.
13.
Arevalo JF, Sanchez JG, Wu L, et al. Primary intravitreal bevacizumab for
diffuse diabetic macular edema: the Pan-American Collaborative Retina
Study Group at 24 months. Ophthalmology 2009;116(8):1488-97.
14.
Nguyen QD, Shah SM, Heier JS, et al. Primary End Point (Six Months)
Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-
2)
study. Ophthalmology 2009; 116:2175–2181.
15.
Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the rani-
bizumab for edema of the mAcula in diabetes (READ-2) study. Ophthal-
mology 2010;117:2146–2151.
16.
Soheilian M, Ramezani A, Bijanzadeh B, et al. Intravitreal bevacizumab
(
avastin) injection alone or combined with triamcinolone versus macular
photocoagulation as primary treatment of diabetic macular edema. Reti-
na 2007;27:1187–1195.
17.
Kreutzer TC, Al SR, Kook D, l. Comparison of intravitreal bevacizumab
versus triamcinolone for the treatment of diffuse diabetic macular edema.
Ophthalmologica 2010;224:258–264
18.
Diabetic Retinopathy Clínical Research Network. A randomized trial
comparing intravitreal triamcinolone acetonide and focal/grid photocoa-
gulation for diabetic macular edema. Ophthalmology 2008;115:1447-
1459.
19.
Chew E, Strauber S, Beck R, et al, Diabetic Retinopathy Clínical Research
Network. Randomized trial of peribulbar triamcinolone acetonide with
and without focal photocoagulation for mild diabetic macular edema: a
pilot study. Ophthalmology 2007;114:1190-1196.
20.
Elman MJ, Aiello LP, Beck RW, et al. Randomized trial evaluating ranibi-
zumab plus prompt or deferred laser or triamcinolone plus prompt laser
for diabetic macular edema. Ophthalmology 2010;117(6):1064-1077. D
RCR.net
21.
Mitchell P, Bandello F, Schmidt-Erfurth U, et al. The RESTORE study: rani-
bizumab monotherapy or combined with laser versus laser monotherapy
for diabetic macular edema. Ophthalmology 2011;118(4):615-625.
22.
Nguyen QD, Shah SM, Khwaja AA, et al. Two-year outcomes of the rani-
bizumab for edema of the mAcula in diabetes (READ-2) study. Ophthal-
mology 2010;117:2146–2151.
23.
Chan CKM, Lai TYY, Mohamed S, et al. Combined high-dose sub-tenon
triamcinolone, intravitreal bevacizumab, and laser photocoagulation for
refractory diabetic macular edema: a pilot study. Retina 2012;32(4):672-
678.
24.
Kang SW, Park SC, Cho HY, Kang JH. Triple therapy of vitrectomy, intra-
vitreal triamcinolone, and macular laser photocoagulation for intractable
diabetic macular edema. Am J Ophthalmol 2007;144(6):878-885.
25.
Haller J a, Qin H, Apte RS, et al. Vitrectomy outcomes in eyes with